BiOpTo: Tomgraphic phase micross for bidical applications (Q84172): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Removed claim: EU contribution (P835): 1,297,608.1199999999 euro) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 1,297,608.1199999999 Euro / rank | |||||||||||||||
| Property / EU contribution: 1,297,608.1199999999 Euro / qualifier | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 1,297,608.1199999999 Euro / qualifier | |||||||||||||||
| |||||||||||||||
Revision as of 05:53, 23 September 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BiOpTo: Tomgraphic phase micross for bidical applications |
Project in Poland financed by DG Regio |
Statements
5,406,700.5 zloty
0 references
5,406,700.5 zloty
0 references
1,297,608.1199999999 Euro
0.24 Euro
13 January 2020
0 references
100.0 percent
0 references
1 November 2016
0 references
31 January 2022
0 references
POLITECHNIKA WARSZAWSKA
0 references
The main goal of the project is to develop, test and prepare for commercialization (TRL7) a novel tool for quantitative 3D analysis of phase biological microobjects namely the tomographic phase microscope (TPM). TPM is working with projections acquired within a limited angular range, which are captured sequentially or through an innovative system of parallel projections. The system of computational imaging provides full processing path: from digital acquisition of investigated object’s projections up to 3D visualization. The TPM supports such biomedical applications as histopathology, traceable measurement of cells and tissues, advanced therapy medicinal products for the treatment of osteoarthritis, cancer and cardiac diseases. In the course of the project, an initial business plan will be created in order to prepare the TPM for commercialization. (Polish)
0 references
The main of the project is to develop, test and formulated for commercialising (TRL7).TPM is working with projections appropriate within a limited angaroo range.The system of Computing and mapping provides full processing path:from digital acquisition of investment objective’s projections to 3D work.The TPM supplies suitable biomarkers for the treatment of osteothritis, cancer and cardiac diseases.In the course of the project, an initial business plan will be created in order to make the TPM for commercialisation. (English)
0 references
Identifiers
POIR.04.04.00-00-1C1D/16
0 references